Kanada - Kiingereza - Health Canada

boehringer ingelheim (canada) ltd ltee - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide (ipratropium bromide monohydrate) 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics

Kanada - Kiingereza - Health Canada

teva canada limited - ipratropium bromide; salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics

Kanada - Kiingereza - Health Canada

apotex inc - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide (ipratropium bromide monohydrate) 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics

Kanada - Kiingereza - Health Canada

boehringer ingelheim (canada) ltd ltee - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 20mcg; 100mcg - ipratropium bromide (ipratropium bromide monohydrate) 20mcg; salbutamol (salbutamol sulfate) 100mcg - antimuscarinics antispasmodics

Kanada - Kiingereza - Health Canada

juno pharmaceuticals corp. - ipratropium bromide (ipratropium bromide monohydrate); salbutamol (salbutamol sulfate) - solution - 0.5mg; 2.5mg - ipratropium bromide (ipratropium bromide monohydrate) 0.5mg; salbutamol (salbutamol sulfate) 2.5mg - antimuscarinics antispasmodics

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - salbutamol sulfate -

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 2.4 mg/ml (equivalent: salbutamol, qty 2 mg/ml) - inhalation - excipient ingredients: sodium chloride; sulfuric acid; water for injections - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Australia - Kiingereza - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 1.2 mg/ml (equivalent: salbutamol, qty 1 mg/ml) - inhalation - excipient ingredients: sodium chloride; water for injections; sulfuric acid - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Kenya - Kiingereza - Pharmacy and Poisons Board

adcock ingram ltd. p.o. box 101674-00101 nairobi - bromhexine hcl 4mg orciprenaline sulphate 5mg - syrup - bromhexine hcl 4mg orciprenaline sulphate 5mg - expectorants excluding combinations with cough